Humoral and cellular responses to bnt162b2 as a booster following two doses of chadox1 ncov-19 determined using three sars-cov-2 antibody assays and an interferon-gamma release assay: a prospective longitudinal study in healthcare workers

HIGHLIGHTS

• who: Seri Jeong from the Complutense University of Madrid, Spain have published the article: Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers, in the Journal: (JOURNAL)
• what: The authors investigated humoral and cellular responses to a booster dose of BNT162b after two doses of ChAdOx1 nCoV-19 in healthcare workers. Frontiers in Immunology | www.frontiersin.org June 2022 | Volume 13 | Article 859019 Responses to BNT162b2 as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.